Adagio Medical Holdings, Inc. (ADGM)

Adagio Medical Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-79.15	-75.04	-36.59	-23.67
Depreciation & Amortization	1.16	1.39	0.53	0.5
Other Amortization	-	0.01	0.02	-
Loss (Gain) From Sale of Assets	0.51	0.06	0	-
Asset Writedown & Restructuring Costs	49.2	49.2	-	-
Stock-Based Compensation	0.59	0.64	0.44	0.37
Other Operating Activities	1.08	-11.51	7.16	0.07
Change in Accounts Receivable	0.09	0.04	-0.07	0.03
Change in Inventory	2.58	0.63	-2.98	0.04
Change in Accounts Payable	-3.39	-4.56	2.82	0.44
Change in Other Net Operating Assets	5.35	9.69	3.01	-0.17
Operating Cash Flow	-21.99	-29.46	-25.65	-22.41
Capital Expenditures	-1.57	-1.65	-0.33	-0.49
Sale of Property, Plant & Equipment	-	-	-	0
Sale (Purchase) of Intangibles	-	-	-0.01	-0.01
Investing Cash Flow	-1.57	-1.65	-0.34	-0.5
Short-Term Debt Issued	-	-	-	9.5
Long-Term Debt Issued	-	16.5	23	-
Total Debt Issued	-	16.5	23	9.5
Long-Term Debt Repaid	-	-0.87	-1.14	-
Net Debt Issued (Repaid)	-	15.63	21.86	9.5
Issuance of Common Stock	-	-	0.02	0.03
Financing Cash Flow	-	15.63	21.88	9.53
Foreign Exchange Rate Adjustments	-0.03	0.21	-0.05	0.08
Net Cash Flow	-23.59	-15.27	-4.16	-13.31
Free Cash Flow	-23.55	-31.11	-25.99	-22.9
Free Cash Flow Margin	-17192.70%	-5167.28%	-8661.67%	-12118.52%
Free Cash Flow Per Share	-1.53	-4.65	-34.20	-30.48
Cash Interest Paid	-	0.09	0.21	-
Levered Free Cash Flow	-13.26	-25.6	-14.8	-
Unlevered Free Cash Flow	-11.51	-23.78	-13.78	-
Change in Working Capital	4.63	5.79	2.79	0.33

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q